| CDC | Centers for Disease Control and Prevention (U.S.) |
| CH | Congenital hypothyroidism |
| CHD | Center for Health Development (regional health office) |
| DILG | Department of the Interior and Local Government |
| DOH | Department of Health (national health agency, Philippines) |
| ENBS | Expanded newborn screening |
| G6PD | Glucose-6-phosphate dehydrogenase |
| GAL | Galactosemia |
| LGU | Local Government Unit |
| MSUD | Maple syrup urine disease |
| NBS | Newborn bloodspot screening |
| NBSCC | Newborn screening continuity clinic (long-term follow-up) |
| NCNBSS | National Comprehensive Newborn Screening System |
| NIH | National Institutes of Health (Philippines) |
| NNSGRC | National Newborn Screening and Global Resource Center (U.S.) |
| NSC | Newborn Screening Center (screening laboratory) |
| NSF | Newborn Screening Facility (screening specimen collection site) |
| NSRC | Newborn Screening Reference Center (Philippines) |
| PEAS | Performance Evaluation and Assessment Scheme (U.S version) |
| PhilHealth | Philippine Health Insurance Corporation (national health insurance) |
| PIR | Program implementation review |
| PKU | Phenylketonuria |
| PPEAS | Philippine Performance Evaluation and Assessment Scheme |
| TPMF | Taiwan Preventive Medicine Foundation |